| 产品: | FBXL14 抗体 |
| 货号: | DF13005 |
| 描述: | Rabbit polyclonal antibody to FBXL14 |
| 应用: | WB IHC |
| 文献验证: | WB |
| 反应: | Human, Mouse, Rat |
| 预测: | Pig, Bovine, Rabbit, Dog, Chicken, Xenopus |
| 蛋白号: | Q8N1E6 |
| RRID: | AB_2845966 |
产品描述
来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
FBXL14 Antibody detects endogenous levels of total FBXL14.
RRID:
AB_2845966
引用格式: Affinity Biosciences Cat# DF13005, RRID:AB_2845966.
引用格式: Affinity Biosciences Cat# DF13005, RRID:AB_2845966.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
抗原和靶标
免疫原:
A synthesized peptide derived from human FBXL14, corresponding to a region within the internal amino acids.
基因/基因ID:
文献引用
1). SIRT1 Stabilizes β-TrCP1 to Inhibit Snail1 Expression in Maintaining Intestinal Epithelial Integrity to Alleviate Colitis. Cellular and molecular gastroenterology and hepatology, 2024
(PubMed: 38729522)
[IF=7.1]
Application: WB Species: human Sample: Caco2 cells
Figure 3. SIRT1 deacetylates and stabilizes β-TrCP1 protein to downregulate Snail1. (A) Caco2 cells stably expressing shRNAs against SIRT1 were subjected to Western blotting. (B) Caco2 cell lysates were subjected to immunoprecipitation (IP) with anti-β-TrCP1, using normal mouse or rabbit IgG as a control, followed by Western blot analyses. (C) Caco2 cells stably coexpressing β-TrCP1 and shRNAs against SIRT1 were subjected to Western blotting. (D) Caco2 cells treated with or without DSS were subjected to Western blotting. (E) HCT116 cells were treated with 4% DSS for 8 hours and the whole cell lysates were subjected to Western blotting. (F) Caco2 cells stably overexpressing SIRT1 were treated with 4% DSS for 8 hours. Whole-cell lysates were subjected to Western blotting. (G) Caco2 cells stably overexpressing β-TrCP1 were treated with 4% DSS for 8 hours. Whole-cell lysates were subjected to Western blotting. (H) Caco2 cells pretreated with 4% DSS for 8 hours or stably expressing shRNAs against SIRT1 were subjected to qPCR analyses for β-TrCP1. (I) To examine the effects of DSS on ubiquitination of β-TrCP1, 293FT cells were cotransfected with the relevant expression plasmids for 48 hours, followed by treatment with 4% DSS for 12 hours. Before harvesting, cells underwent treatment with 20 μM MG132 for 6 hours. Ubiquitination of β-TrCP1 was examined by denature-IP-western analyses. (J) The β-TrCP1 protein half-lives were measured by CHX assays in Caco2 cells pretreated with 4% DSS for 8 hours. (K and L) To examine the effects of SIRT1 on ubiquitination of β-TrCP1 and Snail1, 293FT cells were cotransfected with indicated expressing plasmids. Cells were treated with 20 μM MG132 for 6 hours before collection. Ubiquitination of Snail1 was examined by denature-IP-western analyses. (M) The β-TrCP1 and Snail1 protein half-lives were measured by CHX assays in Caco2 cells stably overexpressing SIRT1. (N and O) Caco2 cell lysates were subjected to IP with anti-SIRT1 (H) or anti-β-TrCP1 (I), using normal mouse or rabbit IgG as a control, followed by Western blot analyses. (P) HEK-293T cells cotransfected with His/Myc-β-TrCP1 and Flag-SIRT1 were subjected to IP and Western blotting analyses.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.